ORMP logo

Oramed Pharmaceuticals (ORMP) Net Income

Annual Net Income

$5.53 M
+$42.09 M+115.11%

December 1, 2023

Summary

Performance

1-Year Change

+115.11%

3-Year Change

+175.44%

5-Year Change

+138.49%

15-Year Change

+152.72%

ORMP Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.06%
ORMP annual net profit is higher than 85.06% of companies in Healthcare sector

High & Low

All-time High

$5.53 M
ORMP annual net profit is currently at an all-time high

3-Year Low

-$36.56 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ORMP previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

May 9, 2025
ORMP next annual earnings announcement is scheduled for May 9, 2025

OtherORMPprofitabilitymetrics:

Annual Net Margin

-
ORMP annual net profit margin value is unknown

Annual Revenue

$1.34 M
ORMP annual revenue is $1.34 million

Annual Gross Profit

-
ORMP annual gross profit value is unknown

Annual EPS

$0.14
ORMP annual earnings per share is $0.14

Quarterly Net Income

-$19.62 M
-$28.83 M-312.97%

September 1, 2024

Summary

Performance

3-Month Change

-312.97%

1-Year Change

-247.11%

3-Year Change

-86.26%

5-Year Change

-760.48%

ORMP Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.83%
ORMP quarterly net profit is higher than 25.83% of companies in Healthcare sector

High & Low

All-time High

$13.34 M
ORMP quarterly net profit is currently -247.11% below its historical high of $13.34 million

3-Year Low

-$19.62 M
ORMP quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ORMP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORMP next earnings announcement is scheduled for May 9, 2025

OtherORMPprofitabilitymetrics:

Quarterly Net Margin

-
ORMP quarterly net profit margin value is unknown

Quarterly Revenue

-
ORMP quarterly revenue value is unknown

Quarterly Gross Profit

-
ORMP quarterly gross profit value is unknown

Quarterly EPS

-$0.48
ORMP quarterly earnings per share is -$0.48

TTM Net Income

$4.46 M
-$16.40 M-78.60%

September 1, 2024

Summary

Performance

3-Month Change

-78.6%

1-Year Change

-19.19%

3-Year Change

+112.51%

5-Year Change

+135.45%

ORMP TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.83%
ORMP TTM net profit is higher than 83.83% of companies in Healthcare sector

High & Low

All-time High

$20.86 M
ORMP TTM net profit is currently -78.60% below its historical high of $20.86 million

3-Year Low

-$36.56 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ORMP previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORMP next earnings announcement is scheduled for May 9, 2025

OtherORMPprofitabilitymetrics:

Annual Net Margin

-
ORMP annual net profit margin value is unknown

TTM Revenue

-
ORMP TTM revenue value is unknown

TTM Gross Profit

-
ORMP TTM gross profit value is unknown

TTM EPS

$0.11
ORMP TTM earnings per share is $0.11

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$5.53 M
ORMP annual net profit is $5.53 million

Annual Revenue

$1.34 M
ORMP annual revenue is $1.34 million

Annual Cost Of Goods Sold

-
ORMP annual cost of goods sold value is unknown

Annual Operating Expenses

$17.11 M
ORMP annual total operating expenses is $17.11 million

Annual Interest Expense

$2.04 M
ORMP annual interest expense is $2.04 million

Annual Income Tax

$0.00
ORMP annual income tax is $0.00

ORMP Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+115.1%-247.1%-19.2%
3 y3 years+175.4%-86.3%+112.5%
5 y5 years+138.5%-760.5%+135.4%

ORMP Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+115.1%-247.1%at low-78.6%+112.2%
5 y5-yearat high+115.1%-247.1%at low-78.6%+112.2%
alltimeall timeat high+115.1%-247.1%at low-78.6%+112.2%

Oramed Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$19.62 M(-313.0%)
$4.46 M(-78.6%)
Jun 2024
-
$9.21 M(+499.7%)
$20.86 M(+99.5%)
Mar 2024
-
$1.54 M(-88.5%)
$10.46 M(+89.2%)
Dec 2023
$5.53 M(-115.1%)
$13.34 M(-513.9%)
$5.53 M(-133.8%)
Sep 2023
-
-$3.22 M(+169.8%)
-$16.35 M(-19.0%)
Jun 2023
-
-$1.19 M(-64.8%)
-$20.19 M(-31.6%)
Mar 2023
-
-$3.40 M(-60.3%)
-$29.53 M(-19.2%)
Dec 2022
-$36.56 M(+213.3%)
-$8.54 M(+21.0%)
-$36.56 M(+1.8%)
Sep 2022
-
-$7.06 M(-33.0%)
-$35.91 M(+0.6%)
Jun 2022
-
-$10.53 M(+1.0%)
-$35.70 M(+17.5%)
Mar 2022
-
-$10.43 M(+32.1%)
-$30.38 M(+23.7%)
Dec 2021
-$11.67 M(-47.5%)
-
-
Nov 2021
-
-$7.89 M(+15.1%)
-$24.56 M(+10.4%)
Aug 2021
-$22.24 M(+203.6%)
-$6.85 M(+31.6%)
-$22.24 M(+21.0%)
May 2021
-
-$5.21 M(+13.0%)
-$18.38 M(+18.9%)
Feb 2021
-
-$4.61 M(-17.3%)
-$15.46 M(+6.3%)
Dec 2020
-$7.32 M(-36.4%)
-
-
Nov 2020
-
-$5.57 M(+85.9%)
-$14.54 M(+26.3%)
Aug 2020
-$11.51 M(-19.8%)
-$3.00 M(+31.2%)
-$11.51 M(+6.6%)
May 2020
-
-$2.28 M(-38.1%)
-$10.79 M(-14.2%)
Feb 2020
-
-$3.69 M(+45.0%)
-$12.58 M(-0.1%)
Nov 2019
-
-$2.54 M(+11.5%)
-$12.60 M(-12.3%)
Aug 2019
-$14.36 M(+12.8%)
-$2.28 M(-44.0%)
-$14.36 M(-4.3%)
May 2019
-
-$4.07 M(+10.0%)
-$15.00 M(-1.8%)
Feb 2019
-
-$3.70 M(-14.0%)
-$15.28 M(+5.4%)
Nov 2018
-
-$4.30 M(+47.0%)
-$14.50 M(+13.9%)
Aug 2018
-$12.73 M(+21.4%)
-$2.93 M(-32.8%)
-$12.73 M(+1.8%)
May 2018
-
-$4.35 M(+49.3%)
-$12.50 M(+23.6%)
Feb 2018
-
-$2.92 M(+15.2%)
-$10.11 M(-2.6%)
Nov 2017
-
-$2.53 M(-6.1%)
-$10.38 M(-1.0%)
Aug 2017
-$10.48 M(-4.4%)
-$2.70 M(+37.2%)
-$10.48 M(-16.5%)
May 2017
-
-$1.97 M(-38.3%)
-$12.54 M(-0.2%)
Feb 2017
-
-$3.18 M(+20.8%)
-$12.57 M(+12.2%)
Nov 2016
-
-$2.64 M(-44.6%)
-$11.21 M(+2.2%)
Aug 2016
-$10.96 M(+51.6%)
-$4.76 M(+138.5%)
-$10.96 M(+31.8%)
May 2016
-
-$2.00 M(+9.8%)
-$8.32 M(+5.2%)
Feb 2016
-
-$1.82 M(-23.9%)
-$7.91 M(+2.3%)
Nov 2015
-
-$2.39 M(+12.9%)
-$7.73 M(+6.8%)
Aug 2015
-$7.23 M
-$2.12 M(+33.7%)
-$7.23 M(+7.2%)
DateAnnualQuarterlyTTM
May 2015
-
-$1.58 M(-3.3%)
-$6.75 M(-3.5%)
Feb 2015
-
-$1.64 M(-13.7%)
-$6.99 M(+8.1%)
Nov 2014
-
-$1.90 M(+16.4%)
-$6.47 M(+13.6%)
Aug 2014
-$5.70 M(+34.6%)
-$1.63 M(-10.9%)
-$5.70 M(+17.2%)
May 2014
-
-$1.83 M(+63.9%)
-$4.86 M(+13.3%)
Feb 2014
-
-$1.11 M(-0.8%)
-$4.29 M(-2.5%)
Nov 2013
-
-$1.12 M(+42.1%)
-$4.40 M(+3.9%)
Aug 2013
-$4.23 M(+26.6%)
-$791.00 K(-37.0%)
-$4.23 M(-11.3%)
May 2013
-
-$1.26 M(+2.5%)
-$4.77 M(+17.4%)
Feb 2013
-
-$1.23 M(+27.9%)
-$4.06 M(+6.3%)
Nov 2012
-
-$958.80 K(-27.9%)
-$3.82 M(+14.4%)
Aug 2012
-$3.34 M(+114.2%)
-$1.33 M(+141.6%)
-$3.34 M(+20.0%)
May 2012
-
-$550.40 K(-44.1%)
-$2.79 M(+56.6%)
Feb 2012
-
-$985.40 K(+105.9%)
-$1.78 M(+23.8%)
Nov 2011
-
-$478.50 K(-38.1%)
-$1.44 M(-8.0%)
Aug 2011
-$1.56 M(-47.6%)
-$773.00 K(-269.0%)
-$1.56 M(-20.1%)
May 2011
-
$457.40 K(-171.2%)
-$1.95 M(-39.3%)
Feb 2011
-
-$642.80 K(+6.6%)
-$3.22 M(+8.4%)
Nov 2010
-
-$602.80 K(-48.3%)
-$2.97 M(-0.3%)
Aug 2010
-$2.98 M(+7.9%)
-$1.17 M(+44.7%)
-$2.98 M(+34.6%)
May 2010
-
-$806.20 K(+105.6%)
-$2.21 M(+15.3%)
Feb 2010
-
-$392.20 K(-36.0%)
-$1.92 M(-12.2%)
Nov 2009
-
-$612.80 K(+52.9%)
-$2.19 M(-20.8%)
Aug 2009
-$2.76 M(-0.3%)
-$400.90 K(-21.9%)
-$2.76 M(-23.7%)
May 2009
-
-$513.30 K(-22.0%)
-$3.62 M(-7.8%)
Feb 2009
-
-$658.30 K(-44.6%)
-$3.93 M(+8.9%)
Nov 2008
-
-$1.19 M(-5.7%)
-$3.60 M(+30.3%)
Aug 2008
-$2.77 M(-14.4%)
-$1.26 M(+53.4%)
-$2.77 M(-31.5%)
May 2008
-
-$821.00 K(+144.4%)
-$4.04 M(+15.0%)
Feb 2008
-
-$335.90 K(-4.0%)
-$3.51 M(+0.1%)
Nov 2007
-
-$350.00 K(-86.2%)
-$3.51 M(+8.4%)
Aug 2007
-$3.24 M(+680.5%)
-$2.53 M(+756.9%)
-$3.24 M(+228.8%)
May 2007
-
-$295.50 K(-10.8%)
-$984.20 K(+20.7%)
Feb 2007
-
-$331.30 K(+330.3%)
-$815.60 K(+67.9%)
Nov 2006
-
-$77.00 K(-72.5%)
-$485.90 K(+17.2%)
Aug 2006
-$414.60 K(+805.2%)
-$280.40 K(+121.0%)
-$414.60 K(+208.9%)
May 2006
-
-$126.90 K(+7831.3%)
-$134.20 K(+1738.4%)
Feb 2006
-
-$1600.00(-71.9%)
-$7300.00(+28.1%)
Nov 2005
-
-$5700.00
-$5700.00
Aug 2005
-$45.80 K
-
-

FAQ

  • What is Oramed Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Oramed Pharmaceuticals?
  • What is Oramed Pharmaceuticals annual net income year-on-year change?
  • What is Oramed Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Oramed Pharmaceuticals?
  • What is Oramed Pharmaceuticals quarterly net income year-on-year change?
  • What is Oramed Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Oramed Pharmaceuticals?
  • What is Oramed Pharmaceuticals TTM net income year-on-year change?

What is Oramed Pharmaceuticals annual net profit?

The current annual net income of ORMP is $5.53 M

What is the all time high annual net income for Oramed Pharmaceuticals?

Oramed Pharmaceuticals all-time high annual net profit is $5.53 M

What is Oramed Pharmaceuticals annual net income year-on-year change?

Over the past year, ORMP annual net profit has changed by +$42.09 M (+115.11%)

What is Oramed Pharmaceuticals quarterly net profit?

The current quarterly net income of ORMP is -$19.62 M

What is the all time high quarterly net income for Oramed Pharmaceuticals?

Oramed Pharmaceuticals all-time high quarterly net profit is $13.34 M

What is Oramed Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ORMP quarterly net profit has changed by -$32.95 M (-247.11%)

What is Oramed Pharmaceuticals TTM net profit?

The current TTM net income of ORMP is $4.46 M

What is the all time high TTM net income for Oramed Pharmaceuticals?

Oramed Pharmaceuticals all-time high TTM net profit is $20.86 M

What is Oramed Pharmaceuticals TTM net income year-on-year change?

Over the past year, ORMP TTM net profit has changed by -$1.06 M (-19.19%)